ArticleCureus2024
Syphilitic Retinitis: A Rare Presentation of a Resurgent Sexually Transmitted Infection in an HIV-Negative Individual.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Nanomaterial-enhanced biosensors for polycystic ovarian syndrome diagnosis and pathophysiological insights.Mikrochimica acta · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We present a rare presentation of isolated syphilitic retinitis in an HIV-negative man. A 47-year-old male presented to our ophthalmology center with complaints of blurred vision, pain, and redness in the left eye for the past seven days. The best corrected visual acuity for distance was 6/6 and best corrected near visual acuity for near was N6 in the right eye. The best corrected visual acuity for distance was finger counting at 1 m and best corrected near visual acuity for near was <N48 in the left eye. The right eye developed similar features of retinitis after one week; the vision worsened and the best corrected visual acuity for distance was 6/18P and best corrected visual acuity for near was N18. The vision was hand movement and counting fingers in the left eye on this visit. The left eye showed keratic precipitates on the endothelial surface; they were non-granulomatous keratic precipitates. The fundus evaluation with an indirect ophthalmoscope showed dense vitritis with snowballing and yellow colored confluent placoid wreath-like lesions suggestive of acute necrotizing retinitis. The venereal disease research laboratory (VDRL) test was reactive (>1:32), the Treponema Pallidum Hemagglutination Assay was positive, and the patient tested negative for human immunodeficiency virus antibodies. Based on these findings, a diagnosis of syphilitic retinitis was made. The patient was given three doses of 2.4 million units of benzathine penicillin intramuscularly (once a week) and doxycycline 100 mg twice daily for the same period. After completion of treatment, the best corrected visual acuity for distance improved to 6/9 and the best corrected near visual acuity for near improved to N6 in the right eye, and the lesions in the eye resolved. The best corrected visual acuity for distance improved to 6/12 and the best corrected near visual acuity for near improved to N10 in the left eye. If a patient presents with unexplained ophthalmic findings such as uveitis, vitritis, or retinitis, then a diagnosis of syphilis should be considered even if the patient does not give a history of high-risk sexual behaviour. Thus, both the physician at the sexually transmitted infection clinic and the ophthalmologist should be aware of these symptoms and signs and consider this as a potential diagnosis. This will result in prompt investigations, appropriate diagnosis, and clinical management, and eventually prevent loss of vision.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.